A patient loses 30 pounds, lowers their A1C, and improves their blood pressure within months of starting a GLP-1 medication. Stories like these are hard to ignore, and they have helped fuel growing enthusiasm around drugs like Ozempic, Wegovy, and Mounjaro. Yet as prescriptions continue to expand beyond high-risk diabetes …
Read More »Using Time in Range to Adjust Therapy: A Practical Guide for Clinicians
The clinical use of time in range is changing how clinicians approach diabetes management. Instead of focusing only on A1C, many providers now rely on continuous glucose monitoring data to guide daily decisions. But how do you translate numbers into action? Think of it like a GPS for glucose control. …
Read More »GLP-1s and Health Economics: Are They Cost-Effective in High-Risk Populations?
GLP-1 receptor agonists have transformed type 2 diabetes and obesity management, but the cost-effectiveness of GLP-1 therapies is now at the center of payer and policy debates. With drugs like semaglutide, liraglutide, dulaglutide, and tirzepatide expanding beyond glycemic control into cardiovascular and weight management, a key question remains: do their …
Read More »Prescribing Exercise in Type 2 Diabetes: What the Evidence Says About Type, Dose, and Impact
Exercise is a cornerstone of type 2 diabetes care, yet clinicians often struggle with translating broad guidelines into practical, individualized “exercise prescriptions.” The focus keyword in this article, exercise prescription for type 2 diabetes, reflects a high‑intent search term that clinicians, diabetes educators, and patients frequently use when seeking actionable …
Read More »Can Digital Twins Improve Individualized Diabetes Management?
Imagine a virtual version of yourself, a “mirror you” inside a computer, where doctors and you can test different treatments, diets, or lifestyle changes — without any risk. This is not science fiction anymore. In recent years, researchers have begun applying the concept of “digital twins diabetes” — virtual patient …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.